Genmab A-S
Price & Volume
Stats
See more52W Range | $19.02-$31.88 |
Market Cap | $12.4B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $19.8B |
Revenue Growth (YoY) | 17.6% |
Gross Profit (12 Mos) | $19B |
Diluted EPS | $1.01 |
News
See moreYahoo Finance • 9 days ago
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Yahoo Finance • 11 days ago
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024
Yahoo Finance • 4 months ago
Genmab A/S (GMAB): Leading Innovation in Antibody Therapeutics
Yahoo Finance • 4 months ago
Is Genmab A/S (GMAB) One of the Best Revenue Growth Stocks to Buy According to Analysts?
About
CEO | Dr. Jan G.J. van de Winkel Ph.D. |
CFO | Mr. Anthony Pagano CPA |
Address | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,635 |
